New patient transfer board takes prime position in GBUK’s Banana range

NewsGuard 100/100 Score

GBUK Healthcare is expanding its Banana range of patient moving and handling products with the launch of a new patient transfer board called the Banana Board Prime.

The brand new ultimate seated transfer board will sit within the Banana range, which was launched by GBUK Healthcare, part of the GBUK Group, back in November 2014.

The cost affective new board has been developed to support independent movement and ensure a smooth and comfortable transfer for patients.

Developed from the manufacturer of the Banana Q2 Board, the Banana Board Prime is ultra-strong, lightweight and easy to carry - with non-slip pads to ensure safe movement for patients. Its curved shape allows both side-to-side and straight patient transfers.

Jeremy Wilkinson, Sales Director of GBUK Healthcare, said: “We are delighted to extend our Banana range, which are tailored to meet end-user needs and improve quality of patient life.

We continue to look forward to the Banana range becoming synonymous with the patient moving and handling area of healthcare.

Customers can buy the products directly from the website – with free delivery for all orders over £70 http://www.bananahealthcare.com/

For more information about the Banana product range, which includes slide sheets and transfer boards, visit http://www.gbukhealthcare.com/products-page/banana

Source:

Medilink

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI in healthcare shows promise in trials but needs real-world testing to ensure effectiveness